The long-term weight management picture has one part that doesn't make it into most ads: stopping GLP-1 therapy is consistently associated with weight regain in clinical extension studies
And with tools like Zepbound, getting better sleep might finally be within reach
As a result, many countries with public health systems face distressing decisions about whether to reimburse these drugs and, if so, for which groups
In practice, clinics adapt trial titration schedules by starting most patients at 1 mg once weekly for 24 weeks, which is considered the safest entry point for minimizing GI side effects
In contrast, more than 80% of those starting SGLT2 or insulin added another medication
Consider tracking your mood, energy, and sexual desire alongside your treatment journey